SKYE BIOSCIENCE
Skye Bioscience is a biopharmaceutical company focused on discovering, developing and commercializing new chemical entities from a class of chemically diverse compounds called cannabinoids, designed to alleviate a variety of diseases and symptoms by selectively targeting CB1 and CB2 receptors. Skye Bioscience is developing a novel and proprietary class of product candidates that are designed to target the body's nervous and immune systems without inducing many of the undesirable side effects typically associated with currently available therapeutics.
SKYE BIOSCIENCE
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2011-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.skyebioscience.com
Total Employee:
1+
Status:
Active
Contact:
(949) 396-0330
Email Addresses:
[email protected]
Total Funding:
43.84 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Microsoft Exchange Online Amazon Office 365 Mail GoDaddy DNS Google Google Cloud COVID-19
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Aptose Biosciences
Aptose Biosciences is a biopharmaceutical company focused on the discovery, research and development of novel, first-in-class
Oyster Point Pharmaceuticals
Oyster is a clinical stage pharmaceutical company focused on the discovery development & commercialization .
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Samorn Biosciences
Samorn Biosciences is a pharmaceuticals industry that focuses on the development, medical affairs and commercial services.
Stealth BioTherapeutics
Stealth BioTherapeutics is a clinical-stage biotechnology company focused on genetic diseases.
Current Employees Featured
Founder
Stock Details
Investors List
SCHNEIDER Brothers
SCHNEIDER Brothers investment in Post-IPO Equity - Skye Bioscience
Midtown Partners
Midtown Partners investment in Post-IPO Equity - Skye Bioscience
TYLT Ventures
TYLT Ventures investment in Post-IPO Equity - Skye Bioscience
TYLT Ventures
TYLT Ventures investment in Post-IPO Equity - Skye Bioscience
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-03 | Skye Bioscience Retains Novotech as CRO for Phase 1 Trial of Glaucoma Drug Candidate |
| 2021-10-05 | Skye Bioscience Appoints Kaitlyn Arsenault as Chief Financial Officer |
Official Site Inspections
http://www.skyebioscience.com
- Host name: 46.34.188.35.bc.googleusercontent.com
- IP address: 35.188.34.46
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
